Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    15252707 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed AFTER: Altering Fat Through Estrogen and Raloxifene
Condition: Postmenopause
Interventions: Drug: conjugated estrogens;   Drug: Raloxifene;   Behavioral: exercise plus mild caloric restriction for weight loss
2 Completed Women's Health Initiative (WHI)
Conditions: Bone Diseases;   Breast Neoplasms;   Cardiovascular Diseases;   Colonic Neoplasms;   Coronary Disease;   Heart Diseases;   Myocardial Ischemia;   Osteoporosis;   Postmenopause
Interventions: Drug: hormone replacement therapy;   Drug: estrogens;   Drug: progestins;   Drug: estrogen replacement therapy;   Behavioral: diet, fat-restricted;   Drug: calcium;   Drug: vitamin D;   Behavioral: dietary supplements
3 Active, not recruiting Timing Estrogen After MenoPaUSe
Condition: Insulin Resistance
Intervention: Drug: Estradiol

Indicates status has not been verified in more than two years